Plain-English translation of NCT06482073 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is testing whether analyzing the genes in your lung tissue and blood samples can help doctors understand your lung cancer better and create a personalized treatment plan for you. Researchers will collect blood or saliva from you, review tissue samples that may have already been taken as part of your regular care, and perform genetic testing to look for specific mutations or changes that might affect your treatment options.
Lung cancers are often caused by different genetic changes from person to person. By understanding the specific genetic makeup of your cancer, doctors hope to recommend treatments that are most likely to work for your particular type of cancer, rather than using a one-size-fits-all approach.
You likely qualify if…
You likely don't qualify if…
You will meet with a genetic counselor who will explain genetic testing and answer your questions. You will provide a blood or saliva sample and give permission for the research team to access tissue samples that were already collected during your bronchoscopy or surgery as part of regular care. Your medical records will be reviewed, and genetic testing will be performed on your samples. Once testing is complete, you and your healthcare provider will receive the results, which may help guide your treatment decisions.
AI-generated summary from trial data · Sep 3, 2026 · Not medical advice
United States
Sponsor
Mayo Clinic
Enrollment target
~250 participants
Started
June 2024
Primary completion
July 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Thoracic Research
Mayo Clinic in Rochester
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.